![]() |
|
|
Lipid Metabolism Laboratory, Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, MA, and * LipoScience, Incorporated, Raleigh, NC
2To whom correspondence should be addressed. E-mail: Ernst.Schaefer{at}tufts.edu.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: gender lipoproteins lipoprotein subclasses low fat diet low cholesterol diet
Coronary heart disease (CHD)2 is a major cause of death and disability in both men and women in the United States (1). Significant risk factors for CHD include age, hypertension, diabetes, cigarette smoking, decreased concentrations of HDL cholesterol (HDL-C < 1.03 mmol/L) and elevated concentrations of LDL cholesterol (LDL-C
4.14 mmol/L) (2). Male gender also carries a greater risk of CHD (2). The National Cholesterol Education Program (NCEP) recommended that a diet restricted in saturated fat (<7% of total energy) and cholesterol (<200 mg/d) should be consumed by subjects with established CHD or at risk of developing CHD to lower their LDL-C (2,3).
We and others documented previously that under controlled conditions, a diet restricted in total fat, saturated fat and cholesterol can lower LDL-C concentrations by 1520%, but also lowers HDL-C concentrations (47). There is a high degree of variability in responsiveness to a low fat diet, which is related in part to gender (812).
The purpose of this study was to compare the effects of a diet restricted in total fat, saturated fat and cholesterol, relative to those of an average American diet (AAD), on plasma lipoprotein and apolipoprotein (apo) concentrations as well as on lipoprotein subspecies in men and women. Our data indicate that, in middle aged and elderly subjects, men respond to restriction in total fat, saturated fat and cholesterol differently from women. Our study does not provide information on the specific component of the diet that is responsible for the observed gender difference in lipoprotein response.
| SUBJECTS AND METHODS |
|---|
|
|
|---|
Subjects participating in this study (n = 33) were moderately hypercholesterolemic at screening (LDL-C
4.14 mmol/L). Inclusion criteria for enrollment into the study included age
40 y, and all women in the study were postmenopausal. None of the subjects were taking medications known to affect lipoprotein metabolism (cholesterol-lowering medications, hormones, and ß-blockers). At the screening visit, all subjects provided a complete medical history and underwent a physical examination. Subjects with any evidence of thyroid disease, diabetes mellitus, kidney disease or liver disease, as well as subjects who smoked or consumed alcohol were not enrolled into the study.
Subjects were grouped by gender, with 19 men and 14 women. The number of subjects with apo E phenotypes 2/3, 3/3, and 3/4, were 3, 11 and 5, respectively, in men and 3, 8 and 3, respectively, in women. Table 1 shows the characteristics of the subjects at screening. Subjects consumed the AAD for 6 wk and then the Therapeutic Lifestyle Changes (TLC) diet, restricted in total fat, saturated fat and cholesterol, for 6 wk. A period of 27 wk, during which subjects could resume their habitual diet, separated the AAD and TLC diet phases. The study protocol was approved by the Tufts University-New England Medical Center Investigation Review Board and all subjects provided informed consent.
|
All food and drink for the AAD and the TLC diets were prepared by the Metabolic Research Unit of the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University and were provided to the participants as breakfast, lunch, dinner and snacks. Blood pressure and body weight were measured at least three times per week. Energy intake was adjusted to keep each subjects body weight constant (±1 kg) throughout the study.
The composition of the AAD diet was similar to diets consumed in the United States (13), and consisted of 35.4% of energy as fat, 14.1% as saturated fat and 147 mg cholesterol/4.2 MJ (Table 2). The TLC diet was composed of 25.5% of energy as fat, 4.0% as saturated fat and 45 mg cholesterol/4.2 MJ. This diet meets the recommendations of the NCEP Adult Treatment Panel III [(2); 25%35% of energy as total fat, <7% as saturated fat, <200 mg/d cholesterol] and Panel II (3). The complete chemical composition of the diets was assessed by Hazelton Laboratories (Madison, WI) in terms of protein, carbohydrate, fat, fatty acids, and cholesterol, and is shown in Table 2. Food sources for the AAD and TLC diets were similar.
|
Blood was drawn into 0.15% EDTA tubes after a 12- to 14-h fast. Blood samples for plasma lipid measurements were collected at wk 4, 5 and 6 of the AAD diet and the TLC diet.
VLDL (d <1.006 kg/L) and the d >1.006 kg/L infranatant were separated by ultracentrifugation at 4°C in a Beckman 50.3 Ti rotor at 109,000 x g for 18 h. HDL fractions (HDL and HDL3) were isolated from plasma by the dextran sulfate-Mg2+ method, after precipitation of apo Bcontaining lipoproteins or apo Bcontaining lipoproteins and HDL2 as previously described (14,15).
The plasma concentrations of total triacylglycerol (TG), total cholesterol (TC), HDL-C, HDL3-C and the 1.006 kg/L infranatant cholesterol were measured on an Abbott Diagnostics Spectrum CCX bichromatic analyzer (Dallas, TX), using Abbott and Miles Technicon enzymatic reagents (16). VLDL, LDL and HDL2 cholesterol concentrations were calculated as follows: VLDL-C = TC - 1.006 kg/L infranatant cholesterol; LDL-C = 1.006 kg/L infranatant cholesterol - HDL-C; HDL2-C = HDL-C - HDL3-C (16). TG concentrations were measured in the fasting state and in the postprandial state. For the measurement of postprandial TG, plasma samples were collected at the end of each diet phase during a constant feeding period during which subjects consumed hourly meals for 20 h with each meal containing 5% of the energy consumed for the day, and food containing the same content for that phase. Ten blood samples were collected between 5 and 20 h after feeding had begun. Within- and between-run CV for the lipid measurements were all < 5%.
Plasma concentrations of apo AI and apo B were measured by noncompetitive ELISA using affinity purified polyclonal antibodies as previously described (17,18). Between- and within-run CV for these assays were
10%.
To determine the plasma concentration of lipoprotein particles containing apo AI without apo AII (LpAI) and of lipoprotein particles containing apo AI and apo AII (LpAI:AII) a differential rocket immunoelectrophoresis assay was used (19). CV between and within run were 4.6 and 1.5%, respectively.
NMR measurements of lipoprotein subclasses.
NMR spectroscopy was used to assess the concentration of different lipoprotein subclasses in Dr. Otvos laboratory (20). This methodology is based on the observation that each lipoprotein particle of a given size has a distinctive lipid NMR signal, whose intensity is proportional to its lipid mass concentration. By computer deconvolution of the composite plasma lipid signal envelope, the signal intensities (and hence concentrations) of 15 subclasses of VLDL, LDL and HDL were determined simultaneously. The designations and estimated diameter ranges (in nm) of the subclasses quantified by NMR were as follows: VLDL6, 150 ± 70; VLDL5, 70 ± 10; VLDL4, 50 ± 10; VLDL3, 38 ± 3; VLDL2, 33 ± 2; VLDL1, 29 ± 2; intermediate density lipoprotein (IDL), 25 ± 2; LDL3, 22 ± 0.7; LDL2, 20.5 ± 0.7; LDL1, 19 ± 0.7; HDL5, 11.5 ± 1.5; HDL4, 9.4 ± 0.6; HDL3, 8.5 ± 0.3; HDL2, 8.0 ± 0.2; HDL1, 7.5 ± 0.2. Concentrations of VLDL subclasses are expressed in units of TG (mmol/L) and those of IDL, LDL and HDL subclasses in units of cholesterol (mmol/L) (20).
Lipoprotein particle size determinations.
At the end of each diet phase, plasma samples were obtained to measure HDL and LDL particle size by nondenaturing polyacrylamide agarose gradient gel electrophoresis (216% for LDL and 430% for HDL) (21,22). Mean HDL particle size and weighted LDL scores were calculated by the equations previously reported (22,23).
Statistical analysis.
Statistical Analysis System software (SAS Institute, Cary, North Carolina) was used to analyze the data. Within each gender, paired Students t tests were conducted to test for differences between mean values during the TLC and the AAD diet phases. Individual percentage changes were calculated as (TLC value - AAD value)/AAD value x 100. Differences in lipoprotein response (percentage change) between men and women were tested for significance using Students t test. P-values < 0.05 were considered significant.
| RESULTS |
|---|
|
|
|---|
|
|
Effects of dietary modification on lipoprotein subclasses concentrations, as assessed by NMR, are shown in Figures 1and 2. In men (Fig. 1), the TLC diet reduced IDL, HDL5 and HDL3 subclasses (P < 0.05). In women (Fig. 2), the TLC diet decreased VLDL2 and HDL5 subclasses (P < 0.05). No gender differences were observed in the response of lipoprotein subclasses to diet.
|
|
| DISCUSSION |
|---|
|
|
|---|
4.14 mmol/L made them candidates for dietary therapy. We used the TLC diet, low in saturated fat and cholesterol and relatively high in carbohydrate and monounsaturated fatty acids, as dietary therapy. Only a few studies have examined the role of gender on the response of lipoprotein subspecies to diet in humans (24,25). Some studies showed that LDL-C lowering in response to low fat, low saturated fat diets was greater in men than in women (8,9,11,12), whereas other studies did not find a gender difference in LDL-C response (26). In a large study with >4000 subjects, the mean reduction in LDL-C in response to the Pritikin Program (<10% of total fat, exercise, and weight reduction over a 3-wk period) was 25% in men and 19% in women, and this gender difference was significant (8). In the Pritikin Program, body weight reduction was also achieved by design during dietary treatment, and body weight changes may have affected the degree of LDL-C response to the diet. In a recent study in which we examined the data from five controlled, isoweight (designed to maintain body weight constant) dietary studies using NCEP Step 2 diets, a nonsignificant trend for greater LDL-C reductions in men than in women was observed (-19 vs. 16%, respectively, P = 0.058) (10). No gender difference in LDL-C response was observed in a study conducted in 63 women and 99 men with hypercholesterolemia who were instructed to follow an American Heart Association step 1 diet (<30% fat, <300 mg cholesterol/d) for 8 wk (27). Similarly, no difference in LDL response to four different low fat diets was observed in 33 women and 30 men with hypercholesterolemia (28). The variability in findings in the current literature may be due to the fact that a large number of subjects may be needed to detect a statistical significance in LDL, or other lipoprotein, response to diet. We showed previously that the degree of LDL-C response to a TLC diet varies greatly among individuals, possibly due to gene-diet interactions (10). In addition, strict adherence to the diet may be a factor in this variability, and controlled studies are best suited to assess the role of diet on lipoprotein changes. In the current study, consumption of a TLC diet under controlled, isoweight conditions significantly reduced LDL-C in both men and women, and this reduction tended to be greater in men than in women (P = 0.08). We also observed a significant reduction in LDL particle size in both men and women. This reduction was likely due to a selective reduction in the larger LDL fractions, as shown by the NMR analysis of LDL subclasses. We reported previously that LDL particle size is reduced, in men and women combined, during consumption of a TLC diet compared with an AAD (29).
Interestingly, although men experienced a significant reduction in postprandial TG concentrations when consuming the TLC diet, this variable tended to increase in women (P = 0.10). This differential response resulted in a significant gender effect. Our results are consistent with a previous observation by Kovar et al. (30) that postprandial TG levels are higher in men than in women consuming a high fat diet, but no such difference is observed when men and women consume a low fat diet.
It is likely that the differential postprandial TG metabolism we observed in our subjects is responsible at least in part for the gender difference in the response of the HDL subclasses to the TLC diet. The TLC-associated reduction in HDL2-C in women was almost twice that in men. HDL2 are large HDL particles, containing both LpAI and LpAI:AII. NMR analysis of HDL subclasses indicated that the larger HDL5 subclass was particularly and significantly reduced by the TLC diet, and this reduction was greater in women than in men. Because a significantly greater reduction in the Lp AI:AII fraction was also observed in men than in women, our data indicate a selective reduction of large LpAI and LpAI:AII HDL in men, and of large Lp A-I in women with the TLC diet. In a previous study of eight subjects (men and women) consuming a TLC diet with an elevated fish content, reductions in Lp AI:AII particles, but not Lp AI particles, were reported (31). Elevated fish consumption alters plasma TG metabolism (32). Therefore the discrepancy in results between our study and that of Cheung et al. (31) may be explained by the difference in the composition of the TLC diet. In a study of hypercholesterolemic subjects, Walden et al. (24) reported that consumption of a TLC diet was associated with a reduction in HDL2-C concentrations that was significantly greater in women than in men. These results are consistent with our observation of a reduction in HDL2 subclasses that was almost twice as large in women than in men. Other investigators have examined alterations in LDL and HDL subclasses, as assessed by gradient gel electrophoresis (33,34). In a study of moderately overweight men, a combined program of dietary modification (step 1 diet), exercise and weight loss over a 1-y period significantly increased large HDL particles only in the group that experienced weight loss (BMI reduction of 2.8 kg/m2), whereas the diet group without exercise did not experience such changes (33). In addition, Dreon et al. (34) observed a significantly greater reduction in LDL-C and apo B levels in response to a low fat diet in men with small LDL particles that in men with a larger LDL particles.
In conclusion, our data are consistent with the concept that middle-aged and elderly men have a more favorable lipoprotein response to a TLC diet than do postmenopausal women. Due to the protective role played by HDL in the atherogenesis process (35,36), it is not known whether the reductions in HDL-C and HDL subclasses that we observed in our study are of relevance in terms of patients risk of CHD.
| FOOTNOTES |
|---|
3 Abbreviations used: AAD, average American diet; apo, apolipoprotein; C, cholesterol; CHD, coronary heart disease; IDL, intermediate density lipoprotein; LpAI, HDL containing apo A-I only; LpAI:AII, HDL containing apo AI and A-II; NCEP, National Cholesterol Education Program; TC, total cholesterol; TG, total triacylglycerol; TLC, therapeutic lifestyle changes. ![]()
Manuscript received 22 May 2003. Initial review completed 14 July 2003. Revision accepted 19 August 2003.
| LITERATURE CITED |
|---|
|
|
|---|
1. American Heart Association (2000) Heart and Stroke Statistical Update 2000 American Heart Association Dallas, TX.
2. The Expert Panel (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J. Am. Med. Assoc. 285:2486-2497.
3. The Expert Panel (1993) Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). J. Am. Med. Assoc. 269:3015-3023.[Medline]
4. Schaefer, E. J., Lichtenstein, A. H., Lamon-Fava, S., Contois, J. H., Li, Z., Rasmussen, H., McNamara, J. R. & Ordovas, J. M. (1995) Efficacy of a National Cholesterol Education Program Step 2 diet in normolipidemic and hypercholesterolemic middle-aged and elderly men and women. Arterioscler. Thromb. Vasc. Biol. 15:1079-1085.
5. Clevidence, B. A., Reichman, M. E., Judd, J. T., Muesing, R. A., Schatzkin, A., Schaefer, E. J., Li, Z., Jenner, J., Brown, C. C. & Sunkin, M. (1995) Effects of alcohol consumption on lipoproteins of premenopausal women. A controlled diet study. Arterioscler. Thromb. Vasc. Biol. 15:179-184.
6. Williams, P. T., Dreon, D. M. & Krauss, R. M. (1995) Effects of dietary fat on high-density-lipoprotein subclasses are influenced by both apolipoprotein E isoforms and low-density- lipoprotein subclass patterns. Am. J. Clin. Nutr. 61:1234-1240.
7. Glatz, J. F., Turner, P. R., Katan, M. B., Stalenhoef, A. F. & Lewis, B. (1993) Hypo- and hyper-response of serum cholesterol level and low density lipoprotein production and degradation to dietary cholesterol in man. Ann. N. Y. Acad. Sci. 676:163-179.[Abstract]
8. Barnard, R. J. (1991) Effects of life-style modification on serum lipids [see comments]. Arch. Intern. Med. 151:1389-1394.[Abstract]
9. Clifton, P. M., Noakes, M. & Nestel, P. J. (1994) Gender and diet interactions with simvastatin treatment. Atherosclerosis 110:25-33.[Medline]
10. Schaefer, E. J., Lamon-Fava, S., Ausman, L. M., Ordovas, J. M., Clevidence, B. A., Judd, J. T., Goldin, B. R, Wood, M., Gorbach, S. & Lichtenstein, A. H. (1997) Individual variability in lipoprotein cholesterol response to National Cholesterol Education Program Step 2 diets. Am. J. Clin. Nutr. 65:823-830.
11. Denke, M. A. & Grundy, S. M. (1994) Individual responses to a cholesterol-lowering diet in 50 men with moderate hypercholesterolemia. Arch. Intern. Med. 154:317-325.[Abstract]
12. Denke, M. A. (1994) Individual responsiveness to a cholesterol-lowering diet in postmenopausal women with moderate hypercholesterolemia. Arch. Intern. Med. 154:1977-1982.[Abstract]
13. National Center for Health Statistics (1983) National Health and Nutrition Examination Survey. Dietary Intake Source Data 1983:48-52 Office of Health Research Statistics and Technology Hyattsville, MD.
14. Warnick, G. R., Benderson, J. & Albers, J. J. (1982) Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin. Chem. 28:1379-1388.
15. Warnick, G. R., Benderson, J. & Albers, J. J. (1982) Quantitation of high density lipoprotein subclasses after separation by dextran sulfate and Mg2+ precipitation. Clin. Chem. 28:1574.
16. McNamara, J. R. & Schaefer, E. J. (1987) Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin. Chim. Acta 166:1-8.[Medline]
17. Schaefer, E. J., Lamon-Fava, S., Cohn, S. D., Schaefer, M. M., Ordovas, J. M., Castelli, W. P. & Wilson, P.W.F. (1994) Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J. Lipid Res. 35:779-792.[Abstract]
18. Schaefer, E. J., Lamon-Fava, S., Ordovas, J. M., Cohn, S. D., Schaefer, M. M., Castelli, W. P. & Wilson, P.W.F. (1994) Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. J. Lipid Res. 35:871-882.[Abstract]
19. Parra, H. J., Mezdour, H., Ghalim, N., Bard, J. M. & Fruchart, J. C. (1990) Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates. Clin. Chem. 36:1431-1435.
20. Otvos, J. D., Jeyarajah, E. J., Bennett, D. W. & Krauss, R. M. (1992) Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin. Chem. 38:1632-1638.
21. McNamara, J. R., Campos, H., Ordovas, J. M., Peterson, J., Wilson, P. W. & Schaefer, E. J. (1987) Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study. Arteriosclerosis 7:483-490.
22. Li, Z., McNamara, J. R., Ordovas, J. M. & Schaefer, E. J. (1994) Analysis of high density lipoproteins by a modified gradient gel electrophoresis method. J. Lipid Res. 35:1698-1711.[Abstract]
23. Campos, H., Genest, J. J., Jr, Blijlevens, E., McNamara, J. R., Jenner, J. L., Ordovas, J. M., Wilson, P. W. & Schaefer, E. J. (1992) Low density lipoprotein particle size and coronary artery disease. Arterioscler. Thromb. 12:187-195.
24. Walden, C. E., Retzlaff, B. M., Buck, B. L., Wallick, S., McCann, B. S. & Knopp, R. H. (2000) Differential effect of National Cholesterol Education Program (NCEP) Step II diet on HDL cholesterol, its subfractions, and apolipoprotein A-I levels in hypercholesterolemic women and men after 1 year. The beFIT Study. Arterioscler. Thromb. Vasc. Biol. 20:1580-1587.
25. Denke, M. A. (1995) Review of human studies evaluating individual dietary responsiveness in patients with hypercholesterolemia. Am. J. Clin. Nutr. 62:471S-477S.
26. Stefanick, M. L., Mackey, S., Sheehan, M., Ellsworth, N., Haskell, W. L. & Wood, P. D. (1998) Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. N. Engl. J. Med. 339:12-20.
27. Geil, P. B., Anderson, J. W. & Gustafson, N. J. (1995) Women and men with hypercholesterolemia respond similarly to an American Heart Association step I diet. J. Am. Diet. Assoc. 95:436-441.[Medline]
28. Howard, B. V., Hannah, J. S., Heiser, C. C. & Jablonski, K. A. (1995) Effects of sex and ethnicity on responses to a low-fat diet: a study of African Americans and whites. Am. J. Clin. Nutr. 62:488S-492S.
29. Schaefer, E. J., Lichtenstein, A. H., Lamon-Fava, S., Contois, J. H., Li, Z., Goldin, B. R., Rasmussen, H., McNamara, J. R. & Ordovas, J. M. (1996) Effects of National Cholesterol Education Program Step 2 diets relatively high or relatively low in fish-derived fatty acids on plasma lipoproteins in middle-aged and elderly subjects. Am. J. Clin. Nutr. 63:234-241.
30. Kovar, J. & Poledne, R. (2000) Sex differences in the response of postprandial lipemia to a change from a low-fat low-cholesterol diet to a high-fat high-cholesterol diet. Physiol. Res. 49:233-239.[Medline]
31. Cheung, M. C., Lichtenstein, A. H. & Schaefer, E. J. (1994) Effects of a diet restricted in saturated fatty acids and cholesterol on the composition of apolipoprotein A-Icontaining lipoprotein particles in the fasting and fed states. Am. J. Clin. Nutr. 60:911-918.
32. Roche, H. M. & Gibney, M. J. (2000) Effect of long-chain n-3 polyunsaturated fatty acids on fasting and postprandial triacylglycerol metabolism. Am. J. Clin. Nutr. 71:232S-237S.
33. Williams, P. T., Krauss, R. M., Stefanick, M. L., Vranizan, K. M. & Wood, P. D. (1994) Effects of low-fat diet, calorie restriction, and running on lipoprotein subfraction concentrations in moderately overweight men. Metabolism 43:655-663.[Medline]
34. Dreon, D. M., Fernstrom, H. A., Miller, B. & Krauss, R. M. (1994) Low-density lipoprotein subclass patterns and lipoprotein response to a reduced-fat diet in men. FASEB J 8:121-126.[Abstract]
35. Buring, J. E., OConnor, G. T., Goldhaber, S. Z., Rosner, B., Herbert, P. N., Blum, C. B., Breslow, J. L. & Hennekens, C. H. (1992) Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction. Circulation 85:22-29.
36. Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Jr, Bangdiwala, S. & Tyroler, H. A. (1989) High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79:8-15.
This article has been cited by other articles:
![]() |
J. Tay, G. D. Brinkworth, M. Noakes, J. Keogh, and P. M. Clifton Metabolic effects of weight loss on a very-low-carbohydrate diet compared with an isocaloric high-carbohydrate diet in abdominally obese subjects. J. Am. Coll. Cardiol., January 1, 2008; 51(1): 59 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Konhilas and L. A. Leinwand The Effects of Biological Sex and Diet on the Development of Heart Failure Circulation, December 4, 2007; 116(23): 2747 - 2759. [Full Text] [PDF] |
||||
![]() |
K. F Hilpert, S. G West, P. M Kris-Etherton, K. D Hecker, N. M Simpson, and P. Alaupovic Postprandial effect of n-3 polyunsaturated fatty acids on apolipoprotein B-containing lipoproteins and vascular reactivity in type 2 diabetes Am. J. Clinical Nutrition, February 1, 2007; 85(2): 369 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Mooradian, M. J. Haas, and N. C. W. Wong The Effect of Select Nutrients on Serum High-Density Lipoprotein Cholesterol and Apolipoprotein A-I Levels Endocr. Rev., February 1, 2006; 27(1): 2 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. T. Raitakari, T. Ronnemaa, M. J. Jarvisalo, T. Kaitosaari, I. Volanen, K. Kallio, H. Lagstrom, E. Jokinen, H. Niinikoski, J. S.A. Viikari, et al. Endothelial Function in Healthy 11-Year-Old Children After Dietary Intervention With Onset in Infancy: The Special Turku Coronary Risk Factor Intervention Project for Children (STRIP) Circulation, December 13, 2005; 112(24): 3786 - 3794. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J Bulpitt Secondary prevention of coronary heart disease in the elderly Heart, March 1, 2005; 91(3): 396 - 400. [Full Text] [PDF] |
||||
![]() |
D. Mozaffarian, E. B Rimm, and D. M Herrington Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1175 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, S. Lamon-Fava, J. Otvos, A. H. Lichtenstein, W. Velez-Carrasco, J. R. McNamara, J. M. Ordovas, and E. J. Schaefer Fish Consumption Shifts Lipoprotein Subfractions to a Less Atherogenic Pattern in Humans J. Nutr., July 1, 2004; 134(7): 1724 - 1728. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||